Skip to content
Open access

TCF21 loss identifies a conserved inflammation-associated fibroblast state across Crohn’s disease and ulcerative colitis

Oct 2026 · bioRxiv · 0 citations
Biology

TL;DR

TCF21 loss identifies a conserved inflammation-associated fibroblast state across CD and UC, supporting stromal reprogramming as a therapeutic concept in IBD.

Abstract

Background and Aims Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are associated with stromal remodeling; however, the fibroblast states that contribute to chronic inflammation remain incompletely defined. We aimed to identify conserved pathogenic fibroblast programs across CD and UC and determine whether these states are linked to loss of homeostatic stromal regulators. Methods We integrated publicly available single-cell RNA sequencing datasets from healthy and inflamed intestinal tissues to define stromal populations across CD, UC, and control samples. Fibroblast subsets were annotated using cluster-specific markers and patient-level abundance analyses. Multiplex immunofluorescence of human gastrointestinal tissue microarrays assessed protein expression. Human colonic fibroblasts were stimulated with IL1B and TNF to model inflammation-associated fibroblast polarization, and restoration of homeostatic factors was evaluated using mRNA-loaded lipid nanoparticles (LNPs). Results A conserved inflammation-associated fibroblast (IAF) population was expanded in both CD and UC and expressed inflammatory chemokines, matrix-remodeling genes, and activation markers including CXCL1, MMP3, FAP, and PDPN. In contrast, a homeostatic ADAMDEC1/TCF21-enriched fibroblast population was reduced in inflamed tissue. TCF21 expression positively correlated with ADAMDEC1 and negatively correlated with activation markers. Multiplex immunofluorescence confirmed depletion of TCF21-positive non-immune, stromal cells in IBD tissue. In vitro, IL1B and TNF induced an IAF-like phenotype and reduced TCF21. TCF21 mRNA-LNP restoration attenuated inflammatory mediators including IL1B and IL6. Conclusions TCF21 loss identifies a conserved inflammation-associated fibroblast state across CD and UC. Restoring TCF21 partially suppresses inflammatory fibroblast programs, supporting stromal reprogramming as a therapeutic concept in IBD.

Read PDF

Similar papers

Open access Sep 2026

Large-scale transcriptomic meta-analysis identifies constitutive and inflammation-dependent layers in ulcerative colitis

Ulcerative colitis (UC) is a chronic inflammatory bowel disease for which the vast majority of the approved therapies target the immune system. We aimed to identify consistently dysregulated genes and pathways across independent UC transcriptomic cohorts, highlighting constitutive and inflammation-dependent changes. We...

M. Piernik, Małgorzata Adamiec-Organiściok, M. Skonieczna et al. · 0 citations
Oct 2026

LILRB3 as an ulcerative colitis-associated molecular biomarker: integrated transcriptomic, single-cell, and experimental validation.

OBJECTIVE Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by mucosal inflammation and immune dysregulation. Although macrophage-mediated inflammation is associated with UC progression, its molecular basis remains incompletely understood. This study integrated bioinformatic analyses and exp...

Bo Yang, Dong-Jie Sun, Zhu Liu et al. · 0 citations
Open access Sep 2026

Integrative transcriptomic analysis links epithelial PCK1 dysregulation to ulcerative colitis and acetyl-l-carnitine-mediated inflammatory modulation.

BACKGROUND Ulcerative colitis (UC) is a chronic inflammatory disorder characterized by persistent mucosal injury and disturbed immune-metabolic homeostasis. Increasing evidence indicates that metabolic remodeling of intestinal epithelial cells contributes to UC-associated inflammation; however, the key metabolic regula...

Yong-Zhuo Li, K. Yu, He Duan et al. · 0 citations
Open access Oct 2026

Transcriptome-wide Differential Expression and Splicing in Inflammatory Bowel Disease Patients

The inflammatory bowel diseases (IBD), comprising mainly Crohn’s disease (CD) and ulcerative colitis (UC), are characterized by chronic intestinal inflammation driven in part by complex genetic and gene regulatory mechanisms. Although transcriptomic studies have defined broad expression changes in IBD, the contribution...

Shu-Ying Han, Emma Yu-Chen Huang, Sophie Silverstein et al. · 0 citations
Open access Sep 2026

Tolerogenic dendritic cells modulate macrophage inflammatory response in Ulcerative colitis: role of IL-1RN

Ulcerative colitis (UC) is a chronic, idiopathic inflammatory disease whose pathogenesis involves various immune cells. Measures that suppress the inflammatory responses of intestinal macrophages are considered crucial for improving ulcerative colitis. In recent years, research on tolerogenic dendritic cells (Tol...

Xuan Yan, Hui-Dong Zhang, Xian-Jie Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.